ERBB2 and breast carcinoma: Rates of cell invasion by ACTA2 silencing decreased to 50.59% (HER2 overexpressed MDA-MB231 cells) and 51.67% (4T1 mammary carcinoma cells) of the vec-alone cells (Figure 5B and 5E).